Watermark
  Back to Search Results

BGB-A317-B167-102

Withdrawn

Safety, Pharmacokinetics and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab in Participants With Solid Tumors in Chinese Participants

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-B167-102

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05644626

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Locations

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents